Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) EPS (Weighted Average and Diluted) (2020 - 2025)

Precision Biosciences (DTIL) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with $2.58 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 194.16% to $2.58 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.6 through Dec 2025, down 360.87% year-over-year, with the annual reading at -$3.56 for FY2025, 442.31% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $2.58 at Precision Biosciences, up from -$1.84 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $4.67 in Q2 2024, with the low at -$23.84 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$2.03, with a median of -$0.46 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 6173.68% in 2022, then soared 249.2% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.38 in 2021, then crashed by 6173.68% to -$23.84 in 2022, then surged by 103.48% to $0.83 in 2023, then crashed by 430.12% to -$2.74 in 2024, then soared by 194.16% to $2.58 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $2.58, -$1.84, and -$2.13 for Q4 2025, Q3 2025, and Q2 2025 respectively.